Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

Competition in U.S. Health Care Markets

May 21, 2025
By Stephen T. Parente, Director The HEAL Network

Disaggregating Innovation: Labor Productivity Gains from Biologic vs. Small Molecule Drugs and Implications of U.S. Drug Pricing Policy

May 7, 2025
By Stephen T. Parente, PhD Alice Chen and PhD Bryana Mayer, MBA

How America Subsidizes the World’s Medicine

July 12, 2024

Changes to domestic drug pricing policies can make foreign countries pay a larger share

Mercatus Center

By Satya Marar and Jacob James Rich

This Is How President Biden ‘Beat Medicare’

July 9, 2024

His Inflation Reduction Act leaves patients with less access to medicines and higher premiums.

Wall Street Journal

By Tomas J. Philipson

FTC Releases Interim Staff Report on Prescription Drug Middlemen

July 9, 2024

Report details how prescription drug middleman profit at the expense of patients by inflating drug costs and squeezing Main Street pharmacies

Federal Trade Commission

Scroll to Top